WS Data Solutions
Discounted Cash Flow Rating
Sell
Return on Equity Rating
Sell
Debt to Equity Rating
Sell
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Wall Street Data Solutions Rating
Neutral
B
Alpine Immune Sciences, Inc. Common Stock (ALPN)
Pharmaceutical Preparations
https://www.alpineimmunesciences.com
Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company dedicated to discovering and developing protein-based immunotherapies to treat autoimmune and inflammatory diseases. Its approach includes a proprietary scientific platform that converts native immune system proteins into differentiated, multi-targeted therapeutics. Its pipeline candidates are; ALPN-303, or povetacicept, is a dual antagonist of the B cell activating factor, or BAFF, and a proliferation-inducing ligand, or APRIL, cytokines, which play key roles in the activation, development, and survival of B cells, and ALPN-101, or acazicolcept, is a dual Inducible T cell Costimulator, or ICOS, and CD28 antagonist intended for the treatment of autoimmune and inflammatory diseases.
188 EAST BLAINE ST., SUITE 200
SEATTLE, WA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
06/17/2015
Market Cap
4,456,779,835
Shares Outstanding
58,000,000
Weighted SO
58,097,961
Total Employees
N/A
Upcoming Earnings
08/12/2024
Similar Tickers
Beta
0.9690
Last Div
0.0000
Range
8.33-65.0
Chg
0.0100
Avg Vol
2371991
Mkt Cap
4456779835
Exch
NASDAQ
Country
US
Phone
206 788 4545
DCF Diff
40.3771
DCF
-0.1471
Div Yield
0.0000
P/S
78.8518
EV Multiple
-97.6180
P/FV
12.5043
Div Yield %
0.0000
P/E
-112.9391
PEG
-1.7925
Payout
0.0000
Current Ratio
9.5617
Quick Ratio
9.4982
Cash Ratio
1.0241
DSO
3.5066
DIO
0.0006
Op Cycle
3.5072
DPO
2610.7204
CCC
-2607.2132
Gross Margin
0.9897
Op Margin
-0.9086
Pretax Margin
-0.6499
Net Margin
-0.6517
Eff Tax Rate
-0.0018
ROA
-0.0986
ROE
-0.1486
ROCE
-0.1504
NI/EBT
1.0028
EBT/EBIT
0.7153
EBIT/Rev
-0.9086
Debt Ratio
0.0258
D/E
0.0290
LT Debt/Cap
0.0255
Total Debt/Cap
0.0282
Int Coverage
305.6786
CF/Debt
-8.3428
Equity Multi
1.1231
Rec Turnover
104.0902
Pay Turnover
0.1398
Inv Turnover
583000.0000
FA Turnover
6.5169
Asset Turnover
0.1513
OCF/Share
-1.2579
FCF/Share
-1.2644
Cash/Share
4.7735
OCF/Sales
-1.4251
FCF/OCF
1.0051
CF Coverage
-8.3428
ST Coverage
-84.7895
CapEx Coverage
-195.0363
Div&CapEx Cov
-195.0363
P/BV
12.5043
P/B
12.5043
P/S
78.8518
P/E
-112.9391
P/FCF
-55.0471
P/OCF
-51.6477
P/CF
-51.6477
PEG
-1.7925
P/S
78.8518
EV Multiple
-97.6180
P/FV
12.5043
DPS
0.0000